Literature DB >> 27778154

ST2-Based Precision Medicine in Device Management: the Next Frontier Beyond MADIT-CRT?

Antoni Bayes-Genis1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27778154     DOI： 10.1007/s12265-016-9715-z

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


× No keyword cloud information.
  5 in total

1.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

Review 2.  Using ST2 in cardiovascular patients: a review.

Authors:  Lori B Daniels; Antoni Bayes-Genis
Journal:  Future Cardiol       Date:  2014-07

3.  Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.

Authors:  Hicham Skali; Robert Gerwien; Timothy E Meyer; James V Snider; Scott D Solomon; Craig M Stolen
Journal:  J Cardiovasc Transl Res       Date:  2016-10-31       Impact factor: 4.132

4.  Contributions of cardiovascular mortality to Spanish life expectancy from 1980 to 2009.

Authors:  Juan M García González
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2013-09-04

5.  Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

Authors:  Domingo A Pascual-Figal; Jordi Ordoñez-Llanos; Pedro L Tornel; Rafael Vázquez; Teresa Puig; Mariano Valdés; Juan Cinca; Antoni Bayes de Luna; Antoni Bayes-Genis
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.